David Junkin | What’s Behind The Biotech Sector’s Rebound For The Wall Street Journal
June 05, 2017 David Junkin
Here’s a great piece by DAVID JUNKIN for The Wall Street Journal! The article is called “What’s Behind the Biotech Sector’s Rebound: Biotech ETFs has investors’ hearts pumping again. Fund buying after Donald Trump’s election helped. The Nasdaq Biotechnology Index fell 21% in 2016 but is up 11% so far in 2017. ” Will risks remain? Huge thanks to Sheryl for a great assignment!
Previous 